Danaher Co. (NYSE:DHR) Shares Purchased by Gladstone Institutional Advisory LLC

Gladstone Institutional Advisory LLC raised its stake in Danaher Co. (NYSE:DHR) by 94.7% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,882 shares of the conglomerate’s stock after acquiring an additional 1,402 shares during the quarter. Gladstone Institutional Advisory LLC’s holdings in Danaher were worth $801,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of DHR. Good Life Advisors LLC acquired a new stake in Danaher during the third quarter valued at $217,000. Oak Thistle LLC acquired a new position in Danaher in the 2nd quarter worth about $363,000. Duality Advisers LP purchased a new position in Danaher during the first quarter worth approximately $5,573,000. Diversified Trust Co grew its holdings in Danaher by 75.4% in the second quarter. Diversified Trust Co now owns 4,360 shares of the conglomerate’s stock valued at $1,090,000 after purchasing an additional 1,874 shares during the period. Finally, Intech Investment Management LLC increased its position in shares of Danaher by 15.6% in the first quarter. Intech Investment Management LLC now owns 15,657 shares of the conglomerate’s stock valued at $3,910,000 after buying an additional 2,116 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on DHR. Wolfe Research upgraded Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price on the stock in a research report on Thursday. TD Cowen lifted their price objective on Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Bank of America raised their target price on Danaher from $270.00 to $275.00 and gave the company a “neutral” rating in a research report on Wednesday, July 24th. Evercore ISI increased their price objective on Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a research note on Tuesday, October 1st. Finally, UBS Group lowered their target price on shares of Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a research note on Wednesday, October 23rd. Six investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $287.16.

Danaher Price Performance

Danaher stock opened at $247.76 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The company has a market capitalization of $178.95 billion, a price-to-earnings ratio of 47.28, a price-to-earnings-growth ratio of 4.45 and a beta of 0.83. The company’s 50 day simple moving average is $266.95 and its 200-day simple moving average is $260.51. Danaher Co. has a 1 year low of $190.95 and a 1 year high of $281.70.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. During the same period last year, the business posted $2.02 earnings per share. The company’s quarterly revenue was up 3.1% on a year-over-year basis. As a group, equities research analysts expect that Danaher Co. will post 7.51 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were paid a dividend of $0.27 per share. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.44%. Danaher’s dividend payout ratio (DPR) is presently 20.61%.

Insider Transactions at Danaher

In related news, SVP Georgeann Couchara sold 952 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $268.37, for a total transaction of $255,488.24. Following the sale, the senior vice president now directly owns 4,212 shares of the company’s stock, valued at $1,130,374.44. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.